Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Corcept Therapeutics Inc
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. It is also conducting advanced clinical trials in patients with solid tumors, Amyotrophic Lateral Sclerosis (ALS) and liver disease. It operates through the discovery, development and commercialization of the pharmaceutical products segment. It sells Korlym and a generic version of Korlym in the United States using sales representatives to call on physicians caring for patients with hypercortisolism (Cushing’s syndrome). The Company's portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. It sells and distributes Lifyorli in the United States. It is developing its proprietary, selective cortisol modulator, relacorilant, as a treatment for patients with hypercortisolism.
Find out what a historical investment in Corcept Therapeutics Inc would be worth today using our CORT stock calculator.
Market Capitalisation
$8.99B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
215
High today
$84.27
Low today
$82.13
Open price
$0.00
52-week high
$91.00
52-week low
$28.66
Ready to start your investing journey with Stake?
Open an accountHow do I buy CORT shares in Australia?
Buying CORT shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Corcept Therapeutics Inc in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CORT
What is the ticker symbol of Corcept Therapeutics Inc?
The ticker symbol for Corcept Therapeutics Inc is CORT.
How much is one share of CORT?
One share of CORT is valued at $83.73 as of 17 June 2026.
What is the market capitalisation of Corcept Therapeutics Inc CORT?
As of 17 June 2026 Corcept Therapeutics Inc has a market cap of $8.99B.
What is the P/E ratio of CORT?
The Price to Earnings ratio of CORT is 236.02.
What is the Earnings Per Share of CORT?
The Earnings Per Share of CORT is $0.35.
What is the 52-week high for Corcept Therapeutics Inc stock?
The Corcept Therapeutics Inc 52-week high stock price is $91.00.
What is the 52-week low for Corcept Therapeutics Inc stock?
The Corcept Therapeutics Inc 52-week low stock price is $28.66.
Can I buy CORT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CORT shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CORT on Stake
- Buy CORT from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CORT from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CORT related stocks